Gts Securities »

Sarepta Therapeutics shares owned by Gts Securities

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Gts Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $12M 92k 124.89
2024-06-30 $22M 141k 158.00
2024-03-31 $22M 166k 129.46
2023-12-31 $40M 414k 96.43
2023-09-30 $37M 302k 121.22

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Tesla Motors Put Option (TSLA)
Apple Put Option (AAPL)
Netflix Put Option (NFLX)
Amazon Put Option (AMZN)
Broadcom Put Option (AVGO)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl C Put Option (GOOG)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)

View all positions for Gts Securities

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
Capital Research and Management Company - Division 3
Henderson Group
State Street Corporation
Wellington Management Company
Farallon Capital Management
venBio Select Advisor
Jpmorgan Chase & Co
Bank of New York Mellon
T. Rowe Price Investment Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Citadel Advisors
Groupama Asset Managment

View all funds holding Sarepta Therapeutics